February 06, 2018
Rose
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems.
from MobiHealthNews http://ift.tt/2BZOJqr
February 06, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Former Apple CEO John Sculley talks healthcare's cultural stagnation, impact of Apple, Amazon- Hintsa Performance raises $7.6M for employee wellbeing platform
- Investors discuss booming, yet crowded, digital health industry at BIO 2018
- Headspace launches subsidiary to focus on prescription meditation apps, digital health
- 92 million user accounts of MyHeritage genealogy website breached
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment